Spain

Spain

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.75 (0.67 - 0.83) 2019 Modelled IHME
0.76 (0.68 - 0.83) 2018 Modelled IHME
0.76 (0.69 - 0.84) 2017 Modelled IHME
0.79 (0.70 - 0.87) 2016 Modelled IHME
0.81 (0.72 - 0.90) 2015 Modelled IHME
0.82 (0.73 - 0.91) 2014 Modelled IHME
0.83 (0.75 - 0.91) 2013 Modelled IHME
0.84 (0.75 - 0.93) 2012 Modelled IHME
0.85 (0.76 - 0.94) 2011 Modelled IHME
0.86 (0.76 - 0.95) 2010 Modelled IHME
0.87 (0.78 - 0.96) 2009 Modelled IHME
0.88 (0.79 - 0.97) 2008 Modelled IHME
0.89 (0.80 - 0.99) 2007 Modelled IHME
0.9 (0.81 - 1) 2006 Modelled IHME
0.91 (0.82 - 1.02) 2005 Modelled IHME
0.92 (0.83 - 1.03) 2004 Modelled IHME
0.93 (0.84 - 1.03) 2003 Modelled IHME
0.94 (0.84 - 1.04) 2002 Modelled IHME
0.95 (0.85 - 1.05) 2001 Modelled IHME
0.96 (0.85 - 1.07) 2000 Modelled IHME
0.97 (0.87 - 1.07) 1999 Modelled IHME
0.98 (0.88 - 1.08) 1998 Modelled IHME
0.99 (0.89 - 1.09) 1997 Modelled IHME
1 (0.89 - 1.10) 1996 Modelled IHME
1.01 (0.90 - 1.12) 1995 Modelled IHME
1.02 (0.91 - 1.12) 1994 Modelled IHME
1.02 (0.93 - 1.13) 1993 Modelled IHME
1.03 (0.93 - 1.15) 1992 Modelled IHME
1.04 (0.94 - 1.16) 1991 Modelled IHME
1.05 (0.95 - 1.18) 1990 Modelled IHME
0 (0 - 1) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.4 (0.80 - 2.20) 2002 Survey/reported Salleras L et al, 2007
0.7 (0.50 - 1) 2009 Survey/reported Pedraza-Flechas et al, 2014
0.8 (0.60 - 1.10) 2016 Modelled ECDC
0.57 (0.44 - 0.72) 2015 Modelled WHO
0.6 (0.40 - 0.90) 2016 Modelled Razavi-Shearer et al, 2018
0.34 (0.32 - 0.37) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.04) 2019 Modelled IHME
0.03 (0.02 - 0.04) 2018 Modelled IHME
0.03 (0.02 - 0.04) 2017 Modelled IHME
0.03 (0.02 - 0.04) 2016 Modelled IHME
0.03 (0.02 - 0.04) 2015 Modelled IHME
0.03 (0.02 - 0.04) 2014 Modelled IHME
0.03 (0.02 - 0.04) 2013 Modelled IHME
0.03 (0.02 - 0.04) 2012 Modelled IHME
0.03 (0.02 - 0.04) 2011 Modelled IHME
0.03 (0.02 - 0.04) 2010 Modelled IHME
0.03 (0.02 - 0.04) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.05) 2005 Modelled IHME
0.04 (0.03 - 0.06) 2004 Modelled IHME
0.06 (0.04 - 0.07) 2003 Modelled IHME
0.07 (0.05 - 0.10) 2002 Modelled IHME
0.09 (0.06 - 0.12) 2001 Modelled IHME
0.1 (0.07 - 0.13) 2000 Modelled IHME
0.1 (0.07 - 0.13) 1999 Modelled IHME
0.1 (0.08 - 0.14) 1998 Modelled IHME
0.1 (0.08 - 0.14) 1997 Modelled IHME
0.11 (0.08 - 0.14) 1996 Modelled IHME
0.11 (0.08 - 0.14) 1995 Modelled IHME
0.13 (0.10 - 0.17) 1994 Modelled IHME
0.18 (0.13 - 0.23) 1993 Modelled IHME
0.24 (0.18 - 0.31) 1992 Modelled IHME
0.33 (0.24 - 0.41) 1991 Modelled IHME
0.41 (0.30 - 0.53) 1990 Modelled IHME
0.19 (0.12 - 0.27) 2015 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.50) 2009 Survey/reported Salleras L et al, 2009
People who inject drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported ECDC
10.5 2015 Survey/reported EMCDDA
11 2014 Survey/reported EMCDDA
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.55 2017 Survey/reported ECDC Monitoring Report
Prisoners
Download
Value (%) Year Type Source
2.6 (0.80 - 4.50) 2008 Survey/reported Garcia-Guerrero J et al, 2010
2.6 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
409,142 (366,537 - 456,797) 1990 Modelled IHME
406,053 (365,147 - 451,313) 1991 Modelled IHME
403,133 (362,020 - 447,512) 1992 Modelled IHME
400,370 (361,873 - 443,057) 1993 Modelled IHME
397,839 (357,366 - 440,442) 1994 Modelled IHME
395,632 (355,078 - 439,159) 1995 Modelled IHME
393,955 (351,959 - 435,265) 1996 Modelled IHME
392,911 (351,709 - 433,971) 1997 Modelled IHME
392,455 (351,476 - 433,372) 1998 Modelled IHME
392,571 (349,590 - 433,269) 1999 Modelled IHME
393,389 (348,828 - 436,272) 2000 Modelled IHME
394,931 (351,991 - 436,273) 2001 Modelled IHME
397,005 (354,631 - 437,564) 2002 Modelled IHME
399,250 (358,655 - 441,258) 2003 Modelled IHME
401,306 (359,930 - 446,186) 2004 Modelled IHME
403,151 (361,010 - 449,329) 2005 Modelled IHME
404,408 (364,262 - 448,249) 2006 Modelled IHME
405,021 (366,023 - 449,225) 2007 Modelled IHME
405,049 (365,840 - 447,692) 2008 Modelled IHME
404,040 (363,247 - 448,168) 2009 Modelled IHME
401,909 (358,739 - 447,513) 2010 Modelled IHME
399,145 (358,344 - 441,248) 2011 Modelled IHME
395,676 (355,689 - 436,583) 2012 Modelled IHME
391,165 (352,535 - 430,408) 2013 Modelled IHME
385,494 (344,148 - 426,038) 2014 Modelled IHME
378,451 (338,422 - 420,903) 2015 Modelled IHME
366,110 (327,988 - 403,164) 2016 Modelled IHME
354,697 (318,096 - 390,819) 2017 Modelled IHME
349,177 (311,975 - 382,700) 2018 Modelled IHME
345,692 (307,911 - 382,208) 2019 Modelled IHME
287,000 (208,000 - 401,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.07 (1.59 - 2.63) 2019 Modelled IHME
2.06 (1.59 - 2.62) 2018 Modelled IHME
2.05 (1.58 - 2.62) 2017 Modelled IHME
2.03 (1.56 - 2.60) 2016 Modelled IHME
2.04 (1.58 - 2.59) 2015 Modelled IHME
2.01 (1.57 - 2.55) 2014 Modelled IHME
2.03 (1.59 - 2.55) 2013 Modelled IHME
2.07 (1.64 - 2.61) 2012 Modelled IHME
2.09 (1.66 - 2.63) 2011 Modelled IHME
2.11 (1.68 - 2.64) 2010 Modelled IHME
2.15 (1.71 - 2.70) 2009 Modelled IHME
2.2 (1.75 - 2.74) 2008 Modelled IHME
2.26 (1.79 - 2.81) 2007 Modelled IHME
2.29 (1.83 - 2.87) 2006 Modelled IHME
2.36 (1.87 - 2.96) 2005 Modelled IHME
2.51 (2 - 3.14) 2004 Modelled IHME
2.8 (2.24 - 3.51) 2003 Modelled IHME
3.09 (2.47 - 3.86) 2002 Modelled IHME
3.33 (2.67 - 4.16) 2001 Modelled IHME
3.47 (2.78 - 4.34) 2000 Modelled IHME
3.57 (2.85 - 4.44) 1999 Modelled IHME
3.57 (2.85 - 4.46) 1998 Modelled IHME
3.57 (2.87 - 4.44) 1997 Modelled IHME
3.63 (2.92 - 4.49) 1996 Modelled IHME
3.63 (2.92 - 4.51) 1995 Modelled IHME
3.64 (2.92 - 4.50) 1994 Modelled IHME
3.67 (2.94 - 4.54) 1993 Modelled IHME
3.72 (2.95 - 4.60) 1992 Modelled IHME
3.79 (3.01 - 4.74) 1991 Modelled IHME
3.81 (2.99 - 4.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
954 (732 - 1,212) 2019 Modelled IHME
951 (733 - 1,210) 2018 Modelled IHME
950 (732 - 1,217) 2017 Modelled IHME
945 (728 - 1,208) 2016 Modelled IHME
953 (738 - 1,208) 2015 Modelled IHME
945 (734 - 1,198) 2014 Modelled IHME
955 (747 - 1,201) 2013 Modelled IHME
977 (772 - 1,229) 2012 Modelled IHME
988 (781 - 1,241) 2011 Modelled IHME
993 (787 - 1,242) 2010 Modelled IHME
1,005 (797 - 1,257) 2009 Modelled IHME
1,016 (805 - 1,265) 2008 Modelled IHME
1,026 (812 - 1,277) 2007 Modelled IHME
1,029 (819 - 1,285) 2006 Modelled IHME
1,043 (827 - 1,307) 2005 Modelled IHME
1,091 (867 - 1,364) 2004 Modelled IHME
1,198 (957 - 1,498) 2003 Modelled IHME
1,299 (1,036 - 1,621) 2002 Modelled IHME
1,379 (1,103 - 1,721) 2001 Modelled IHME
1,415 (1,134 - 1,771) 2000 Modelled IHME
1,439 (1,151 - 1,792) 1999 Modelled IHME
1,427 (1,142 - 1,784) 1998 Modelled IHME
1,416 (1,139 - 1,762) 1997 Modelled IHME
1,434 (1,154 - 1,775) 1996 Modelled IHME
1,428 (1,149 - 1,772) 1995 Modelled IHME
1,426 (1,145 - 1,762) 1994 Modelled IHME
1,435 (1,148 - 1,772) 1993 Modelled IHME
1,449 (1,150 - 1,790) 1992 Modelled IHME
1,474 (1,169 - 1,843) 1991 Modelled IHME
1,479 (1,161 - 1,877) 1990 Modelled IHME
1,610 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
9 (6 - 14) 2019 Modelled IHME
9 (7 - 14) 2018 Modelled IHME
10 (7 - 14) 2017 Modelled IHME
10 (7 - 14) 2016 Modelled IHME
10 (7 - 14) 2015 Modelled IHME
10 (7 - 14) 2014 Modelled IHME
10 (7 - 14) 2013 Modelled IHME
10 (7 - 14) 2012 Modelled IHME
9 (7 - 14) 2011 Modelled IHME
9 (7 - 14) 2010 Modelled IHME
10 (7 - 14) 2009 Modelled IHME
10 (7 - 14) 2008 Modelled IHME
10 (7 - 14) 2007 Modelled IHME
10 (7 - 14) 2006 Modelled IHME
10 (7 - 14) 2005 Modelled IHME
10 (7 - 14) 2004 Modelled IHME
10 (7 - 14) 2003 Modelled IHME
10 (7 - 15) 2002 Modelled IHME
10 (7 - 15) 2001 Modelled IHME
10 (7 - 15) 2000 Modelled IHME
10 (7 - 15) 1999 Modelled IHME
10 (7 - 15) 1998 Modelled IHME
10 (7 - 15) 1997 Modelled IHME
10 (7 - 15) 1996 Modelled IHME
10 (7 - 15) 1995 Modelled IHME
10 (7 - 15) 1994 Modelled IHME
11 (7 - 15) 1993 Modelled IHME
11 (7 - 15) 1992 Modelled IHME
11 (7 - 15) 1991 Modelled IHME
11 (7 - 15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2019 Survey/reported WHO/UNICEF
98 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Source:
HepB birth dose policy
Yes (for risk groups)
Source: Khetsuriani et al 2021
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.98 (0.79 - 1.18) 2019 Modelled IHME
0.97 (0.79 - 1.18) 2018 Modelled IHME
0.96 (0.79 - 1.18) 2017 Modelled IHME
0.95 (0.78 - 1.17) 2016 Modelled IHME
0.95 (0.77 - 1.17) 2015 Modelled IHME
0.95 (0.77 - 1.17) 2014 Modelled IHME
0.95 (0.78 - 1.17) 2013 Modelled IHME
0.96 (0.78 - 1.17) 2012 Modelled IHME
0.96 (0.78 - 1.18) 2011 Modelled IHME
0.97 (0.78 - 1.18) 2010 Modelled IHME
0.95 (0.77 - 1.15) 2009 Modelled IHME
0.89 (0.74 - 1.07) 2008 Modelled IHME
0.83 (0.70 - 0.99) 2007 Modelled IHME
0.78 (0.66 - 0.92) 2006 Modelled IHME
0.76 (0.65 - 0.89) 2005 Modelled IHME
0.77 (0.66 - 0.90) 2004 Modelled IHME
0.8 (0.69 - 0.93) 2003 Modelled IHME
0.84 (0.72 - 0.98) 2002 Modelled IHME
0.88 (0.75 - 1.02) 2001 Modelled IHME
0.91 (0.77 - 1.06) 2000 Modelled IHME
0.93 (0.79 - 1.09) 1999 Modelled IHME
0.96 (0.80 - 1.12) 1998 Modelled IHME
0.98 (0.82 - 1.16) 1997 Modelled IHME
0.99 (0.83 - 1.18) 1996 Modelled IHME
1 (0.83 - 1.20) 1995 Modelled IHME
1 (0.83 - 1.18) 1994 Modelled IHME
1 (0.83 - 1.18) 1993 Modelled IHME
0.99 (0.83 - 1.19) 1992 Modelled IHME
0.98 (0.82 - 1.17) 1991 Modelled IHME
0.96 (0.80 - 1.16) 1990 Modelled IHME
0.8 (0.30 - 1.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
66.5 2015 Survey/reported EMCDDA; Ministry of Health
66.6 2014 Survey/reported EMCDDA; Ministry of Health
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.26 (0.14 - 0.42) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.1 (0.30 - 2.80) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.7 (0.40 - 2.60) 2014 Modelled Gower et al, 2014
1.5 2019 Modelled Jin et al. 2017
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.2 (0.10 - 0.30) 2012 Survey/reported Seisdedos T et al, 2011
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
4.9 (2.90 - 7.50) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
71 (69.50 - 72.50) 2012 Modelled Degenhardt L et al, 2017
64.4 2016 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
64.4 2016 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2 2017 Survey/reported ECDC
4.2 2019 Modelled Jin et al. 2017
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
20.3 (18.90 - 21.70) 2009 Modelled ECDC
44.9 2010 Survey/reported ECDC
42.9 2010 Survey/reported ECDC
38.9 2010 Survey/reported ECDC
37.8 2010 Survey/reported ECDC
37.2 2010 Survey/reported ECDC
33 2010 Survey/reported ECDC
3,029 2010 Survey/reported ECDC
27 2010 Survey/reported ECDC
25.3 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
373,098 (312,073 - 448,613) 1990 Modelled IHME
380,346 (317,400 - 456,471) 1991 Modelled IHME
385,472 (322,283 - 461,816) 1992 Modelled IHME
388,909 (324,559 - 461,727) 1993 Modelled IHME
391,177 (325,071 - 464,104) 1994 Modelled IHME
392,818 (327,496 - 471,711) 1995 Modelled IHME
392,264 (326,699 - 466,099) 1996 Modelled IHME
388,454 (324,733 - 459,196) 1997 Modelled IHME
382,710 (321,478 - 449,014) 1998 Modelled IHME
376,391 (319,115 - 439,283) 1999 Modelled IHME
371,025 (315,380 - 432,581) 2000 Modelled IHME
363,992 (311,497 - 421,258) 2001 Modelled IHME
353,734 (303,115 - 410,016) 2002 Modelled IHME
343,399 (293,238 - 398,822) 2003 Modelled IHME
336,411 (286,805 - 391,747) 2004 Modelled IHME
336,759 (286,536 - 393,156) 2005 Modelled IHME
351,516 (297,774 - 410,351) 2006 Modelled IHME
379,741 (317,058 - 449,310) 2007 Modelled IHME
412,790 (342,003 - 493,427) 2008 Modelled IHME
440,868 (359,544 - 534,174) 2009 Modelled IHME
454,023 (366,214 - 553,771) 2010 Modelled IHME
454,831 (368,718 - 554,713) 2011 Modelled IHME
452,903 (368,055 - 551,639) 2012 Modelled IHME
449,393 (365,910 - 548,846) 2013 Modelled IHME
445,712 (362,784 - 548,586) 2014 Modelled IHME
443,155 (360,779 - 547,620) 2015 Modelled IHME
444,417 (364,762 - 545,120) 2016 Modelled IHME
447,113 (364,529 - 546,947) 2017 Modelled IHME
448,207 (365,948 - 545,068) 2018 Modelled IHME
448,841 (362,710 - 544,260) 2019 Modelled IHME
386,000 (159,000 - 557,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
26,800 (14,000 - 43,100) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
10.5 (8.76 - 12.20) 2019 Modelled IHME
10.4 (8.63 - 12.10) 2018 Modelled IHME
10.3 (8.50 - 12.10) 2017 Modelled IHME
10.2 (8.51 - 12) 2016 Modelled IHME
10.2 (8.49 - 11.90) 2015 Modelled IHME
9.97 (8.34 - 11.70) 2014 Modelled IHME
9.89 (8.27 - 11.60) 2013 Modelled IHME
9.9 (8.28 - 11.60) 2012 Modelled IHME
9.83 (8.21 - 11.50) 2011 Modelled IHME
9.78 (8.16 - 11.50) 2010 Modelled IHME
9.87 (8.23 - 11.60) 2009 Modelled IHME
9.96 (8.30 - 11.70) 2008 Modelled IHME
10.1 (8.35 - 11.90) 2007 Modelled IHME
10.1 (8.39 - 12) 2006 Modelled IHME
10.3 (8.62 - 12.20) 2005 Modelled IHME
10.5 (8.73 - 12.40) 2004 Modelled IHME
10.6 (8.80 - 12.60) 2003 Modelled IHME
10.5 (8.73 - 12.50) 2002 Modelled IHME
10.4 (8.62 - 12.40) 2001 Modelled IHME
10.4 (8.60 - 12.40) 2000 Modelled IHME
10.5 (8.74 - 12.60) 1999 Modelled IHME
10.4 (8.66 - 12.40) 1998 Modelled IHME
10.3 (8.57 - 12.40) 1997 Modelled IHME
10.3 (8.52 - 12.40) 1996 Modelled IHME
10.2 (8.42 - 12.30) 1995 Modelled IHME
10.1 (8.35 - 12.10) 1994 Modelled IHME
10 (8.27 - 12.20) 1993 Modelled IHME
10 (8.23 - 12.20) 1992 Modelled IHME
10 (8.21 - 12.20) 1991 Modelled IHME
9.95 (8.11 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,817 (4,031 - 5,638) 2019 Modelled IHME
4,785 (3,988 - 5,614) 2018 Modelled IHME
4,762 (3,942 - 5,616) 2017 Modelled IHME
4,743 (3,961 - 5,569) 2016 Modelled IHME
4,755 (3,966 - 5,580) 2015 Modelled IHME
4,679 (3,914 - 5,476) 2014 Modelled IHME
4,653 (3,894 - 5,447) 2013 Modelled IHME
4,671 (3,905 - 5,460) 2012 Modelled IHME
4,637 (3,872 - 5,434) 2011 Modelled IHME
4,594 (3,834 - 5,385) 2010 Modelled IHME
4,601 (3,840 - 5,400) 2009 Modelled IHME
4,595 (3,827 - 5,399) 2008 Modelled IHME
4,583 (3,798 - 5,393) 2007 Modelled IHME
4,543 (3,764 - 5,370) 2006 Modelled IHME
4,565 (3,804 - 5,407) 2005 Modelled IHME
4,553 (3,790 - 5,396) 2004 Modelled IHME
4,523 (3,762 - 5,383) 2003 Modelled IHME
4,412 (3,671 - 5,253) 2002 Modelled IHME
4,303 (3,565 - 5,123) 2001 Modelled IHME
4,240 (3,509 - 5,062) 2000 Modelled IHME
4,247 (3,528 - 5,074) 1999 Modelled IHME
4,162 (3,465 - 4,977) 1998 Modelled IHME
4,089 (3,403 - 4,905) 1997 Modelled IHME
4,085 (3,366 - 4,908) 1996 Modelled IHME
4,017 (3,312 - 4,830) 1995 Modelled IHME
3,954 (3,273 - 4,759) 1994 Modelled IHME
3,920 (3,231 - 4,750) 1993 Modelled IHME
3,902 (3,208 - 4,760) 1992 Modelled IHME
3,901 (3,190 - 4,744) 1991 Modelled IHME
3,858 (3,145 - 4,726) 1990 Modelled IHME
4,316 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
55 (45 - 65) 2019 Modelled IHME
55 (45 - 65) 2018 Modelled IHME
55 (45 - 65) 2017 Modelled IHME
55 (45 - 65) 2016 Modelled IHME
55 (44 - 65) 2015 Modelled IHME
55 (44 - 65) 2014 Modelled IHME
55 (44 - 65) 2013 Modelled IHME
55 (44 - 64) 2012 Modelled IHME
55 (44 - 64) 2011 Modelled IHME
54 (44 - 64) 2010 Modelled IHME
54 (44 - 64) 2009 Modelled IHME
54 (43 - 63) 2008 Modelled IHME
53 (43 - 63) 2007 Modelled IHME
53 (42 - 62) 2006 Modelled IHME
52 (42 - 62) 2005 Modelled IHME
52 (42 - 62) 2004 Modelled IHME
52 (42 - 62) 2003 Modelled IHME
52 (41 - 62) 2002 Modelled IHME
52 (41 - 62) 2001 Modelled IHME
52 (41 - 62) 2000 Modelled IHME
52 (41 - 62) 1999 Modelled IHME
52 (41 - 62) 1998 Modelled IHME
51 (41 - 62) 1997 Modelled IHME
51 (40 - 61) 1996 Modelled IHME
51 (40 - 61) 1995 Modelled IHME
51 (40 - 61) 1994 Modelled IHME
51 (40 - 61) 1993 Modelled IHME
50 (40 - 61) 1992 Modelled IHME
50 (40 - 61) 1991 Modelled IHME
50 (41 - 61) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
29,151 2017 Survey/reported ECDC, 2019
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Source:
HepB birth dose policy
Yes (for risk groups)
Source: Khetsuriani et al 2021
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.75 (%)
2019
(0.67 - 0.83(%))
IHME
HCV (RNA/cAg+)
0.98 (%)
2019
(0.79 - 1.18(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.7 (%)
2009
(0.5 - 1(%))
Pedraza-Flechas et al, 2014
HCV (anti-HCV)
1.1 (%)
2003
(0.3 - 2.8(%))
Lopez-Izquierdo R et al, 2007

Hepatitis related deaths (national)

Modelled

HBV
954
2019
(732 - 1,212)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4,817
2019
(4,031 - 5,638)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.02 - 0.04(%))
IHME

Prevalence PWID

HCV
64.40 (%)
2016, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
119
2016
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

Action plan

View all

News

Action plans

Resources

Programs